The role of the SHH gene in prostate cancer cell resistance to paclitaxel

Prostate

Volumn 74, Issue 11, 2014, Pages 1142-1152

  Statkiewicz, Malgorzata ^a   Maryan, Natalia ^b   Lipiec, Agnieszka ^a   Grecka, Emilia ^c   Grygorowicz, Monika A ^a   Omiotek, Marcin ^a   Gorska, Agnieszka ^d   Mikula, Michal ^a   Malecki, Maciej ^d  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c INSTITUTE OF MOTHER AND CHILD   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

ATP binding cassette transporters; multidrug resistance; paclitaxel; sonic Hedgehog

Indexed keywords

PACLITAXEL; SHORT HAIRPIN RNA; SONIC HEDGEHOG PROTEIN;

ARTICLE; CANCER CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; DRUG SENSITIVITY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SONIC HEDGEHOG GENE;

ATP-BINDING CASSETTE TRANSPORTERS; MULTIDRUG RESISTANCE; PACLITAXEL; SONIC HEDGEHOG;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; HEDGEHOG PROTEINS; HUMANS; MALE; PACLITAXEL; PROSTATIC NEOPLASMS; TRANSFECTION; TREATMENT FAILURE; UP-REGULATION;

EID: 84903304358     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22830     Document Type: Article

References (48)

1. Małecki M, Gładysz A, Mościcka K, Lipiec A,. Sonic Hedgehog-morfogen o znaczeniu terapeutycznym. Post Biol Kom 2008; 35: 441-452.
2. Carpenter D, Stone DM, Brush J, Ryan A, Armanini M, Frantz G, Rosenthal A, De Sauvage FJ,. Characterization of two patched receptors for the vertebrate hedgehog protein family. Proc Natl Acad Sci USA 1998; 95: 13630-13634.
3. Dominguez M, Brunner M, Hafen E, Basler K,. Sending and receiving the hedgehog signal: Control by the Drosophila Gli protein Cubitus interruptus. Science 1996; 272: 1621-1625.
4. Kinzler KW, Vogelstain B,. Gli gene encodes a nuclear protein which binds specific sequences in the human genome. Mol Cell Biol 1990; 10: 634-642.
5. Evangelista M, Tian H, De sauvage FJ,. The hedgehog signaling pathway in cancer. Clin Cancer Res 2006; 12: 5924-5928.
6. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA,. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004; 431 (7009): 707-712.
7. Matsui M, Matsui W,. Targeting Hedgehog-A cancer stem cell pathway. Clin Cancer Res 2010; 16: 3130-3140.
8. Gottesman MM,. Mechanisms of cancer drug resistance. Annu Rev Med 2002; 53: 615-627.
9. Dean M,. The Human ATP-Binding Cassette (ABC) Transporter Superfamily. National Center for Biotechnology Information < http://www.ncbi.nlm.nih.gov/ books/NBK3 > 2002.
10. Cui D, Xu Q, Wang K, Che X,. Gli1 is a potential target for alleviating multidrug resistance of gliomas. J Neurol Sci 2010; 288: 156-166.
11. Zhang J, Zhao J, Zhang W, Liu G, Yin D, Li J, Zhang S, Li H,. Establishment of paclitaxel-resistant cell line and the underlying mechanism on drug resistance. Int J Gynecol Cancer 2012; 22: 1450-1456.
12. Sanchez P, Hernández AM, Stecca B, Kahler AJ, Degueme AM, Barrett A, Beyna M, Datta MW, Datta S, Ruiz I, Altaba A,. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA 2004; 101: 12561-12566.
13. Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK,. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Mol Cancer Ther 2007; 6 (3): 967-978.
14. Shafaee Z, Schmidt H, Du W, Posner M, Weichselbaum R,. Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells. Cancer Chemother Pharmacol 2006; 58: 765-770.
15. Chai F, Zhou J, Chen C, Xie S, Chen X, Su P, Shi J,. The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells. Onco Targets Ther 2013; 6: 1643-1647.
16. Steg AD, Katre AA, Bevis KS, Ziebarth A, Dobbin ZC, Shah MM, Alvarez RD, Landen CN,. Smoothened antagonists reverse taxane resistance in ovarian cancer. Mol Cancer Ther 2012; 11 (7): 1587-1597.
17. Singh S, Chitkara D, Mehrazin R, Behrman SW, Wake RW, Mahato RI,. Chemoresistance in Prostate cancer cells is regulated by miRNAs and Hedgehog pathway. PLoS ONE 2012; 7 (6): e40021.
18. Narita S, So A, Ettinger S, Hayashi N, Muramaki M, Fazli L, Kim Y, Gleave ME,. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin Cancer Res 2008; 14: 5769-5777.
19. Honami T, Shimo T, Okui T, Kurio N, Hassan NM, Iwamoto M, Sasaki A,. Sonic hedgehog signaling promotes growth of oral squamous cell carcinoma cells associated with bone destruction. Oral Oncol 2012; 48: 49-55.
20. Coon V, Laukert T, Pedone CA, Laterra J, Kim KJ, Fults DW,. Molecular therapy targeting Sonic hedgehog and hepatocyte growth factor signaling in a mouse model of medulloblastoma. Mol Cancer Ther 2010; 9: 2627-2636.
21. Steinbach D, Gillet JP, Sauerbrey A, Gruhn B, Dawczynski K, Bertholet V, De Longueville F, Zintl F, Remacle J, Efferth T,. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res 2006; 12: 4357-4363.
22. Chapuy B, Koch R, Radunski U, Corsham S, Cheong N, Inagaki N, Ban N, Wenzel D, Reinhardt D, Zapf A, Schweyer S, Kosari F, Klapper W, Truemper L, Wulf GG,. Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration. Leukemia 2008; 22: 1576-1586.
23. Thakur A, Joshi N, Shanmugam T, Banerjee R,. Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: Implications for glioblastoma multiforme therapy. Cancer Lett 2013; 334: 274-283.
24. Liu Q, Liu XJ, Chen YJ, Wang J,. Effect of combination of taxol and celecoxib on reversing multidrug resistance human breast cancer cells (MCF-7/Taxol) and explore its underlying mechanism. Sichuan Da Xue Xue Bao Yi Xue Ban 2011; 42: 326-357.
25. Huisman MT, Chhatta AA, Van Tellingen O, Beijnen JH, Schinkel AH,. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int J Cancer 2005; 116: 824-829.
26. Oguri T, Ozasa H, Uemura T, Bessho Y, Miyazaki M, Maeno K, Maeda H, Sato S, Ueda R,. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer. Mol Cancer Ther 2008; 7: 1150-1155.
27. Liu Y, Peng H, Zhang JT,. Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray. Mol Pharmacol 2005; 68: 430-438.
28. Gillet JP, Efferth T, Steinbach D, Hamels J, DE Longueville F, Bertholet V, Gillet JP, Efferth T, Steinbach D, Hamels J, de Longueville F, Bertholet V, Remacle J,. Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res 2004; 64: 8987-8993.
29. Tian Q, Zhang J, Chan SY, Tan TM, Duan W, Huang M, Zhu YZ, Chan E, Yu Q, Nie YQ, Ho PC, Li Q, Ng KY, Yang HY, Wei H, Bian JS, Zhou SF,. Topotecan is a substrate for multidrug resistance associated protein 4. Curr Drug Metab 2006; 7: 105-118.
30. Chen ZS, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H, Kruh GD,. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res 2002; 62: 3144-3150.
31. Lee K, Klein-szanto AJ, Kruh GD,. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J Natl Cancer Inst 2000; 92: 1934-1940.
32. Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G, Mercer KE, Zhuang Y, Panetta JC, Johnston B, Scheper RJ, Stewart CF, Schuetz JD,. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol 2004; 24: 7612-7621.
33. Wielinga PR, Reid G, Challa EE, Van Der Heijden I, Van Deemter L, De haas M, Mol C, Kuil AJ, Groeneveld E, Schuetz JD, Brouwer C, De Abreu RA, Wijnholds J, Beijnen JH, Borst P,. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol 2002; 62: 1321-1331.
34. Abla N, Chinn LW, Nakamura T, Liu L, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Ferrin TE, Giacomini KM, Kroetz DL,. The human multidrug resistance protein 4 (MRP4, ABCC4): Functional analysis of a highly polymorphic gene. J Pharmacol Exp Ther 2008; 325: 859-868.
35. Tian Q, Zhang J, Tan TM, Chan E, Duan W, Chan SY, Boelsterli UA, Ho PC, Yang H, Bian JS, Huang M, Zhu YZ, Xiong W, Li X, Zhou S,. Human multidrug resistance associated protein 4 confers resistance to camptothecins. Pharm Res 2005; 22: 1837-1853.
36. Porro A, Haber M, Diolaiti D, Iraci N, Henderson M, Gherardi S, Valli E, Munoz MA, Xue C, Flemming C, Schwab M, Wong JH, Marshall GM, Della Valle G, Norris MD, Perini G,. Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells. J Biol Chem 2010; 285: 19532-19543.
37. Hendig D, Langmann T, Zarbock R, Schmitz G, Kleesiek K, Götting C,. Characterization of the ATP-binding cassette transporter gene expression profile in Y79: A retinoblastoma cell line. Mol Cell Biochem 2009; 328: 85-92.
38. Heimerl S, Bosserhoff AK, Langmann T, Ecker J, Schmitz G,. Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res 2007; 17: 265-273.
39. Chen KG, Valencia JC, Gillet JP, Hearing VJ, Gottesman MM,. Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma. Pigment Cell Melanoma Res 2009; 22: 740-749.
40. Zhang Z, Li X, Wang X, Zhou Y, Xu H, Wang J, Huang L, Tian Y, Cheng Q,. The expression of ABCG4, V-ATPase and clinic significance of their correlation with NSCLC. Zhongguo Fei Ai Za Zhi 2008; 11: 691-695.
41. Elliott AM, Al-hajj MA,. ABCB8 mediates doxorubicin resistance in melanoma cells by protecting the mitochondrial genome. Mol Cancer Res 2009; 7: 79-87.
42. Auner V, Sehouli J, Oskay-oezcelik G, Horvat R, Speiser P, Zeillinger R,. ABC transporter gene expression in benign and malignant ovarian tissue. Gynecol Oncol 2010; 117: 198-201.
43. Luque R, Vicente AG, Soberino J, Prados JC, Melguizo C, González rivas CS, Vozmediano JR, Conde V, Garcia JG, Aránega A,. Drug resistance induced by paclitaxel and carboplatin plasmatic concentrations in lung cancer cell lines. J Clin Oncol 2012; 30 (suppl 30): abstr 97.
44. Reinecke P, Schmitz M, Schneider EM, Gabbert HE, Gerharz CD,. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types. Cancer Invest 2000; 18: 614-625.
45. Huang Y, Ibrado AM, Reed JC, Bullock G, Ray S, Tang C, Bhalla K,. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Leukemia 1997; 11: 253-257.
46. Zhu J, Guan Y,. Construction of cancerous multidrug resistant cell model induced by paclitaxel from human leukemia CCRF-CEM cells. Chin J Pharmacol Toxicol 2010; 2: 134-139.
47. Li L, Jiang AC, Dong P, Wan Y, Yu ZW,. The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol. Otolaryngol Head Neck Surg 2007; 137: 659-664.
48. Taipale J, Cooper MK, Maiti T, Beachy PA,. Patched acts catalytically to suppress the activity of Smoothened. Nature 2002; 418: 892-897.